STMN1 and ovarian carcinoma: The expression of stathmin has so far been investigated in only a handful of studies focused on HGSC and the detailed data on LGSC is missing entirely, although it could be of predictive value in tubo-ovarian carcinomas since target-specific anti-stathmin effectors now represent potential therapeutic targets.